N-glycoside

Subclass of:

435 - Chemistry: molecular biology and microbiology

435041000 - MICRO-ORGANISM, TISSUE CELL CULTURE OR ENZYME USING PROCESS TO SYNTHESIZE A DESIRED CHEMICAL COMPOUND OR COMPOSITION

435072000 - Preparing compound containing saccharide radical

435084000 - Preparing nitrogen-containing saccharide

Patent class list (only not empty are listed)

Deeper subclasses:

Class / Patent application number	Description	Number of patent applications / Date published
435089000	Nucleotide	1095
435087000	Nucleoside	32
435086000	Cobalamin (i.e., vitamin B12, LLD factor)	3
20090253180	DIAGNOSIS OF LIVER PATHOLOGY THROUGH ASSESSMENT OF ANTI-GAL IgG GLYCOSYLATION - Methods for diagnosing pathology of the liver in subject suspected of having such pathology by measuring the glycosylation of anti-gal IgG in various biological fluids of the subject.	10-08-2009
20110201054	Process for improved recovery of fermentation products from intracellular and extracellular presence - The present invention increases yield of the target fermented molecules by spray drying the fermentation broth and reducing the process volume to nearly one tenth the original. Thus, none of the target molecules are lost and requirements of the solvent and the other conventional method process equipments and processing materials are reduced considerably. Product recovery is improved. A major saving in the waste water treatment offsets spray drying and offers better process economics.	08-18-2011
20120264174	ASSAY FOR VITAMIN B12 ABSORPTION AND METHOD OF MAKING LABELED VITAMIN B12 - The invention provides methods for labeling vitamin B12 with	10-18-2012

Entries
Document	Title	Date
20100190212	METHOD OF CONTROLLING THE CONTENT OF SELECTED COMPONENT(S) FROM POLYMER(S) USING MOLECULAR SIEVE(S) - The invention provides in a first aspect a method for controlling the content of selected component(s) in one or more polymer(s) by:	07-29-2010
20110159546	PROCESS FOR THE CO-PRODUCTION OF CHITIN, ITS DERIVATIVES AND POLYMERS CONTAINING GLUCOSE, MANNOSE AND/OR GALACTOSE, BY THE FERMENTATION OF THE YEAST PICHIA PASTORIS - The presently disclosed subject matter concerns a process for the co-production of glucosamine polymers (chitin, chitosan or any of its derivatives) and polymers containing glucose, mannose and/or galactose, by the high cell density fermentation of the yeast	06-30-2011
20110165626	HIGH YIELD PRODUCTION OF SIALIC ACID (NEU5AC) BY FERMENTATION - The present invention relates to a method for producing sialic acid, comprising the step of culturing a microorganism in a culture medium, wherein said microorganism comprises heterologous genes encoding a sialic acid synthase (NeuB), a UDP-GlcNAc epimerase (NeuC), said micro-organism being devoid of a gene encoding CMP-Neu5Ac synthase (NeuA) or wherein a gene encoding CMP-Neu5Ac synt hase (NeuA) has been inactivated or deleted; and wherein endogenous genes coding for sialic acid aldolase (NanA), for ManNac kinase (NanK) and for sialic acid transporter (NanT) have been deleted or inactivated. It also relates to the above microorganism.	07-07-2011
20120149067	Methods for producing hyaluronan in a recombinant host cell - The present invention relates to methods for producing a hyaluronic acid, comprising: (a) cultivating a	06-14-2012
20140017729	METHOD FOR MANUFACTURING SUGAR SOLUTION - A method of producing a sugar liquid includes concentrating an aqueous cellulose-derived sugar solution with a nanofiltration membrane and/or reverse osmosis membrane, wherein the concentration is carried out after adding a water-soluble anionic polymer to the aqueous cellulose-derived sugar solution to remove a fermentation inhibitor(s) into a permeate side of the nanofiltration membrane and/or reverse osmosis membrane.	01-16-2014
20140106406	GENE CLUSTER FOR THE PRODUCTION OF GOUGEROTIN, GOUGEROTIN ANALOGUES, AND PRECURSORS THEREOF - The present disclosure relates to the molecular cloning of a gougerotin biosynthetic gene cluster from	04-17-2014
20140315255	NOVEL ANTIBACTERIAL COMPOUNDS, METHODS OF MAKING THEM, AND USES THEREOF - The present invention relates to novel therapeutics with antibacterial activity, processes for their preparation, and pharmaceutical, veterinary and nutritional compositions containing them as active ingredients. The present invention also relates to uses of the novel therapeutics, for example, as medicants or food additives in the treatment of bacterial infections or to aid body mass gain in a subject.	10-23-2014
20160068877	BIOSYNTHETIC PATHWAYS AND PRODUCTS - This disclosure describes biosynthesized compounds including anhydromevalonolactone and β-methyl-δ-valerolactone. This disclosure further describes biosynthetic methods for making these compounds. In some embodiments, the biosynthetic methods can include a combination of biosynthesis and chemical steps to produce β-methyl-δ-valerolactone. Finally, this disclosure described recombinant cells useful for the biosynthesis of these compounds.	03-10-2016